A DNA vaccine candidate provides protection against Rift Valley Fever virus in sheep under natural field conditions
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1628877 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Moufid Mhamadi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Virology Department, The Pasteur Institute of Dakar, Dakar, Senegal. Hauptthemen laut MEDLINE: Rift Valley Fever, Vaccines, DNA, Rift Valley fever virus, Viral Vaccines. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Rift Valley Fever virus (RVFV) is a mosquito-borne zoonotic pathogen, that causes significant morbidity and mortality in livestock, including high abortion rates in pregnant animals and elevated case fatality in neonates, representing a major threat to both animal and human health. Vaccination is the most effective countermeasure to reduce RVFV’s impact. In this study, we designed a veterinary DNA vaccine encoding a consensus RVFV glycoprotein precursor (GPC), optimized for expression in sheep. The construct was evaluated for immunogenicity in mice and sheep and for protective efficacy in sheep raised under natural field conditions in Senegal, West Africa. The vaccine induced robust humoral responses characterized by high neutralizing antibody titers in both mice and sheep. Under natural exposure, vaccinated sheep showed reduced infection rates (3.2%) compared with controls (14.3%), and neutralizing antibody responses persisted for more than one year. Importantly, the vaccine was well tolerated, including in pregnant animals, with no adverse outcomes such as abortions or fetal abnormalities. These findings demonstrate that a DNA-based RVFV vaccine can elicit durable immunity and provide protection in livestock under real-world conditions. This study highlights the potential of DNA vaccines as a safe, effective, and affordable alternative to existing veterinary vaccines and supports their further development as a key strategy to reduce RVFV transmission and improve animal and human health outcomes in endemic regions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Virology Department, The Pasteur Institute of Dakar, Dakar, Senegal.
- Vaccine Research Center, Department of Preclinical Trials, The Institut Pasteur of Dakar, Dakar, Senegal.
- Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, TX, United States.
- Medical Zoology Department, The Pasteur Institute of Dakar, Dakar, Senegal.
- Global Urgent and Advanced Research and Development, Batiscan, Quebec, QC, Canada.
- DIATROPIX, The Pasteur Institute of Dakar, Dakar, Senegal.
Zitieren
APA
Mhamadi, M., Babuadze, G. G., Badji, A., Nepveu-Traversy, M. E., Ndiaye, E. H., Gaye, A., Ndiaye, M., Mhamadi, M., Mendy, F. W., Touré, C. T., Dieng, I., Dia, M., Bob, N. S., de La Vega, M. A., Faye, O., Sall, A. A., Diallo, M., Kobinger, G., Faye, O., & Fausther-Bovendo, H. (2025). A DNA vaccine candidate provides protection against Rift Valley Fever virus in sheep under natural field conditions. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1628877
Vancouver
Mhamadi M, Babuadze GG, Badji A, Nepveu-Traversy ME, Ndiaye EH, Gaye A, et al. A DNA vaccine candidate provides protection against Rift Valley Fever virus in sheep under natural field conditions. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1628877
BibTeX
@article{Mhamadi2025,
author = {Mhamadi, Moufid and Babuadze, George Giorgi and Badji, Aminata and Nepveu-Traversy, Marie-Edith and Ndiaye, El Hadji and Gaye, Alioune and Ndiaye, Mignane and Mhamadi, Moundhir and Mendy, Frank William and Touré, Cheikh Talibouya and Dieng, Idrissa and Dia, Moussa and Bob, Ndeye Sakha and de La Vega, Marc-Antoine and Faye, Ousmane and Sall, Amadou Alpha and Diallo, Mawlouth and Kobinger, Gary and Faye, Oumar and Fausther-Bovendo, Hugues},
title = {A DNA vaccine candidate provides protection against Rift Valley Fever virus in sheep under natural field conditions},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1628877}
}
EUVIMED